Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Inovio Pharmaceuticals, Inc. INO

Full chart Compare
Set alert

Price alert · INO

All alert types
1.62 USD -0.04 (-2.41%)

At closeNov 5, 2026, 8:10 AM EST

1.57 -0.05 -3.09%

Pre-market · Nov 5, 8:10 AM ET

1.55 Day range 1.85
0.56 52-week range 2.72
YTD
-6.90%
1 year
-29.26%

Financial health

Altman Z-Score

-55.19 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.0×
FY 2016: -82.5×FY 2017: -45.9×FY 2018: -45.7×FY 2019: -40.8×FY 2020: -99.3×FY 2021: -42.2×FY 2022: -1.3×FY 2023: -1.0×FY 2024: -0.5×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
P/S 1249×
FY 2016: 14.4×FY 2017: 8.0×FY 2018: 12.1×FY 2019: 79.2×FY 2020: 185×FY 2021: 587×FY 2022: 36.3×FY 2023: 163×FY 2024: 228×FY 2025: 1249×
FY 2016 5y median 228× FY 2025
P/B 3.4×
FY 2016: 4.1×FY 2017: 2.4×FY 2018: 4.3×FY 2019: 94.8×FY 2020: 3.0×FY 2021: 2.6×FY 2022: 1.7×FY 2023: 1.2×FY 2024: 0.7×FY 2025: 3.4×
FY 2016 5y median 1.7× FY 2025
P/FCF -0.9×
FY 2016: -7.6×FY 2017: -4.6×FY 2018: -4.9×FY 2019: -3.3×FY 2020: -7.6×FY 2021: -4.8×FY 2022: -1.7×FY 2023: -1.1×FY 2024: -0.5×FY 2025: -0.9×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA -0.6×
FY 2016: -6.6×FY 2017: -3.7×FY 2018: -3.9×FY 2019: -3.8×FY 2020: -7.8×FY 2021: -3.4×FY 2022: -1.3×FY 2023: -1.2×FY 2024: 0.0×FY 2025: -0.6×
FY 2016 5y median -1.2× FY 2025
EV/Sales 714×
FY 2016: 13.8×FY 2017: 7.4×FY 2018: 11.4×FY 2019: 98.0×FY 2020: 157×FY 2021: 566×FY 2022: 34.9×FY 2023: 182×FY 2024: -19.5×FY 2025: 714×
FY 2016 5y median 182× FY 2025
FCF Yield -109.0%
FY 2016: -13.1%FY 2017: -21.8%FY 2018: -20.4%FY 2019: -30.3%FY 2020: -13.1%FY 2021: -20.8%FY 2022: -58.3%FY 2023: -91.9%FY 2024: -210.4%FY 2025: -109.0%
FY 2016 5y median -91.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -132871.3%
FY 2016: -215.5%FY 2017: -198.1%FY 2018: -308.7%FY 2019: -2702.1%FY 2020: -1674.2%FY 2021: -16972.3%FY 2022: -2607.4%FY 2023: -17300.3%FY 2024: -51616.9%FY 2025: -132871.3%
FY 2016 5y median -17300.3% FY 2025
Net Margin -130000.0%
FY 2016: -208.5%FY 2017: -208.9%FY 2018: -318.1%FY 2019: -2902.8%FY 2020: -2245.4%FY 2021: -17109.9%FY 2022: -2726.7%FY 2023: -16239.9%FY 2024: -49254.3%FY 2025: -130000.0%
FY 2016 5y median -17109.9% FY 2025
ROE -352.5%
FY 2016: -59.8%FY 2017: -61.9%FY 2018: -111.5%FY 2019: -3474.7%FY 2020: -36.1%FY 2021: -76.0%FY 2022: -125.8%FY 2023: -115.1%FY 2024: -156.6%FY 2025: -352.5%
FY 2016 5y median -125.8% FY 2025
ROIC -259.4%
FY 2016: -58.7%FY 2017: -55.1%FY 2018: -98.2%FY 2019: -97.2%FY 2020: -24.8%FY 2021: -69.6%FY 2022: -105.1%FY 2023: -97.5%FY 2024: -139.9%FY 2025: -259.4%
FY 2016 5y median -105.1% FY 2025
ROA -114.3%
FY 2016: -42.5%FY 2017: -47.1%FY 2018: -74.0%FY 2019: -82.9%FY 2020: -30.8%FY 2021: -61.2%FY 2022: -80.3%FY 2023: -79.0%FY 2024: -94.7%FY 2025: -114.3%
FY 2016 5y median -80.3% FY 2025

Growth (YoY)

Revenue -70.0%
FY 2016: -12.8%FY 2017: 19.4%FY 2018: -27.8%FY 2019: -86.5%FY 2020: 80.2%FY 2021: -76.1%FY 2022: 478.2%FY 2023: -91.9%FY 2024: -73.8%FY 2025: -70.0%
FY 2016 FY 2025
Operating Income 22.8%
FY 2016: -122.4%FY 2017: -9.7%FY 2018: -12.5%FY 2019: -18.1%FY 2020: -11.7%FY 2021: -142.8%FY 2022: 11.2%FY 2023: 46.2%FY 2024: 21.9%FY 2025: 22.8%
FY 2016 FY 2025
EPS (diluted) 54.2%
FY 2016: -134.9%FY 2017: -6.9%FY 2018: 2.8%FY 2019: 7.6%FY 2020: -10.3%FY 2021: -32.7%FY 2022: -890.8%FY 2023: 56.7%FY 2024: 35.1%FY 2025: 54.2%
FY 2016 FY 2025
Free Cash Flow 15.0%
FY 2016: -336.9%FY 2017: -10.5%FY 2018: -2.9%FY 2019: -30.7%FY 2020: -81.6%FY 2021: -20.9%FY 2022: -0.1%FY 2023: 42.6%FY 2024: 16.1%FY 2025: 15.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 2.8×FY 2017: 3.9×FY 2018: 2.5×FY 2019: 2.9×FY 2020: 11.3×FY 2021: 6.8×FY 2022: 3.3×FY 2023: 3.6×FY 2024: 2.8×FY 2025: 1.4×
FY 2016 5y median 3.3× FY 2025
Quick Ratio 1.4×
FY 2016: 2.8×FY 2017: 3.9×FY 2018: 2.5×FY 2019: 2.9×FY 2020: 11.3×FY 2021: 6.8×FY 2022: 3.3×FY 2023: 3.6×FY 2024: 2.8×FY 2025: 1.4×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 0.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 29.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.4×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.3×FY 2019: -0.7×FY 2020: 1.4×FY 2021: 0.1×FY 2022: 0.1×FY 2023: -0.1×FY 2024: 0.5×FY 2025: 0.4×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: -547×FY 2017: -3225×FY 2018: 0.0×FY 2019: -14.0×FY 2020: -14.3×FY 2021: -156×FY 2022: -213×FY 2023: -118×FY 2024: -632×FY 2025: 0.0×
FY 2016 5y median -156× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.6%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -2.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31